The House Committee on Oversight and Government Reform asked Johnson & Johnson CEO Bill Weldon to testify at a second hearing to explore the company’s recent massive recalls of over-the-counter medication, according to reports this week (see Reuters and Bloomberg). Weldon was unable to attend the committee’s May 27 hearing because he was recovering from back surgery at the time.
The committee’s letter to Weldon on Tuesday said the second hearing was scheduled for June 30, but the committee later said that the date would be rescheduled, according to reports. Weldon will be expected to discuss J&J’s recent manufacturing and quality-control woes, including the April 30 recall of more than 135 million units of children’s and infants’ products and what the committee’s chairman calls the “phantom recall” of 2008, in which contractors were hired to remove products from store shelves, according to documents produced during and after the May 27 hearing.
Reports could not confirm whether Weldon would attend the upcoming hearing. Also, JNJBTW, the company’s blog, has been silent on the issue since the May 27 posting of the prepared statement made by Colleen Goggins, J&J’s consumer group chairman, to the oversight committee. Goggins attended the hearing in place of the recovering Weldon.